Related Experiment Video
Updated: Jun 17, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Shared treatment decision making improves adherence and outcomes in poorly controlled asthma
Sandra R Wilson1, Peg Strub, A Sonia Buist
1Palo Alto Medical Foundation Research Institute, CA 94301, USA. wilsons@pamfri.org
Shared decision making (SDM) significantly improves asthma medication adherence and clinical outcomes compared to usual care. This patient-centered approach enhances controller and long-acting beta-agonist adherence, leading to better asthma management.
Area of Science:
- Pulmonary Medicine
- Clinical Pharmacy
- Health Services Research
Background:
- Poor adherence to asthma controller medications is a significant barrier to effective treatment.
- Suboptimal medication adherence leads to increased morbidity and healthcare utilization in asthma patients.
Purpose of the Study:
- To compare the impact of shared decision-making (SDM) versus clinician-centered decision-making and usual care on medication adherence and clinical outcomes in adults with poorly controlled asthma.
- To evaluate the effectiveness of a patient-centered approach in improving asthma management.
Main Methods:
- A randomized controlled trial involving 612 adults with poorly controlled asthma.
- Intervention groups received asthma education and structured patient-clinician encounters, with SDM involving negotiation of treatment based on patient goals.
- Usual care served as the control group.
Main Results:
- Shared decision-making (SDM) significantly improved controller medication adherence (CMA 0.67 vs. 0.46) and long-acting beta-agonist adherence (CMA 0.51 vs. 0.40) compared to usual care in Year 1.
- SDM also led to higher cumulative controller medication doses and significantly better clinical outcomes, including quality of life, healthcare use, rescue medication use, asthma control, and lung function.
- Compared to clinician decision-making, SDM showed significantly better adherence and quantitatively improved clinical outcomes.
Conclusions:
- Negotiating treatment decisions with patients significantly enhances adherence to asthma pharmacotherapy.
- Shared decision-making is an effective strategy for improving both medication adherence and clinical outcomes in patients with poorly controlled asthma.
- This patient-centered approach offers a promising model for optimizing asthma management.
Related Concept Videos
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Nursing Management
First, in...
COPD: Management Using Bronchodilators and Corticosteroids
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-III: Symptoms and Complications
Classification of Asthma